Guizhou Sanli Pharmaceutical Co Ltd (603439) — Capital Reinvestment Ratio
Guizhou Sanli Pharmaceutical Co Ltd (603439) has a Capital Reinvestment Ratio of 0.22x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥33.19 Million) in capital expenditures (CN¥7.40 Million). See 603439 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guizhou Sanli Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Guizhou Sanli Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Guizhou Sanli Pharmaceutical Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see how much is Guizhou Sanli Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.42x | CN¥107.07 Million | CN¥45.20 Million | ▲ +7.4% |
| 2023 | 0.39x | CN¥276.70 Million | CN¥108.73 Million | ▼ -3.9% |
| 2022 | 0.41x | CN¥293.29 Million | CN¥119.91 Million | ▲ +143.1% |
| 2021 | 0.17x | CN¥155.04 Million | CN¥26.08 Million | ▼ -79.4% |
| 2020 | 0.82x | CN¥63.25 Million | CN¥51.71 Million | ▲ +1086.3% |
| 2019 | 0.07x | CN¥116.24 Million | CN¥8.01 Million | ▲ +190.9% |
| 2018 | 0.02x | CN¥75.35 Million | CN¥1.78 Million | ▼ -81.0% |
| 2017 | 0.12x | CN¥57.47 Million | CN¥7.17 Million | ▼ -64.6% |
| 2016 | 0.35x | CN¥35.10 Million | CN¥12.36 Million | ▼ -76.8% |
| 2015 | 1.52x | CN¥33.28 Million | CN¥50.53 Million | ▼ -96.7% |
| 2014 | 46.66x | CN¥563.46K | CN¥26.29 Million | ▲ +15913.9% |
| 2013 | 0.29x | CN¥30.09 Million | CN¥8.77 Million | — |